Multiply Labs

We’re thrilled to announce our collaboration with Legend Biotech, focused on automating cell therapy manufacturing! Excited to work with some of the best scientists in the field.  Through this collaboration, Legend Biotech will evaluate our robotic technologies, and secure priority access to those automated systems. The Multiply Labs approach to automating cell therapy manufacturing - as seen in this video - is rooted in the promising results of our  peer-reviewed study in Cytotherapy, which highlighted statistical equivalence between manual and automated cell expansion processes. This collaboration will help showcase the potential of our flexible automation solutions, bringing us closer to our vision of reducing labor costs and increasing manufacturing throughput. Learn more about the news here: https://bit.ly/3TG8JsG   #CellTherapy #Robotics #Innovation #Pharma #BioTech

What do engineers often get wrong about science? And what do scientists often misunderstand about engineering? 🚨 The first episode of our podcast, Cell Mates, is here! 🚨 In this debut episode, we brought together Fred (Federico) Parietti, PhD, robotics engineer and CEO of Multiply Labs, and Sanket Acharya, PhD, scientist and senior director of corporate development at GenScript, to explore how these two worlds collide—and come together—to shape the future of pharma manufacturing. 💡 It’s not just a conversation; it’s a deep dive into collaboration, innovation, and the power of bridging disciplines! Our mission is to bring science and engineering together to build the future of pharma manufacturing, one conversation at a time! Listen to the full episode on ➡️ YouTube: https://lnkd.in/g78W699S ➡️ Spotify: https://lnkd.in/gbgvNagr ➡️ Apple Podcasts: https://lnkd.in/gm84Grab ➡️ Amazon Music: https://lnkd.in/gEeRiWJy #CellMatesPodcast #Pharma #Automation #CellTherapy #AI #Robotics #PodcastLaunch

What’s the biggest difference between how scientists and engineers think? 🤔 What happens when you put scientists and engineers in the same room to brainstorm solutions to some of pharma’s biggest challenges? We explore these very questions and more in our NEW podcast: Cell Mates, the podcast that is building the future of pharma automation, one conversation at a time! 🎧You won’t want to miss this... The first episode, featuring special guest Sanket Acharya, PhD from GenScript, drops this Thursday! EDIT: First episode is out! ➡️ YouTube: https://lnkd.in/g78W699S ➡️ Spotify: https://lnkd.in/gbgvNagr ➡️ Apple Podcasts: https://lnkd.in/gm84Grab ➡️ Amazon Music: https://lnkd.in/gEeRiWJy #CellMatesPodcast #Pharma #Automation #CellTherapy #AI #Robotics #Podcast

Roses are red, our robots are blue (ish), They work with precision, just like we do. 🤖💙 This Valentine’s Day, we’re celebrating perfect pairings—automation and pharma manufacturing, science and technology, and of course… our robotic arms (from our partners over at Universal Robots)!💕 Happy Valentine’s Day from all of us at Multiply Labs! #ValentinesDay #Automation #Robotics

In this insightful discussion, our CEO, Fred (Federico) Parietti, delves into the critical role of trust in driving the adoption of advanced robotics, particularly in high-stakes fields like the biopharma industry. To build trust, we focus on these key principles: 🤝 Partnering with industry-leading organizations 🦾 Carrying out side-by-side comparisons of robotic and manual processes 📰 Publishing the results in peer-reviewed scientific journals Watch the full video to learn more about how we're building trust and driving automation innovation in the biopharma industry. #Robotics #Innovation #Biopharma #Data

A scientist says: “We can cure this.” An engineer says “Let’s automate it”. Throw them together in a room, and suddenly the future of pharma manufacturing starts getting built! Stay tuned for our NEW podcast, Cell Mates—where science meets engineering to discuss the future of pharma manufacturing! First episode drops Thursday, February 20th.🎙️ #Pharma #Automation #Podcast #CellTherapy #AI #Robotics

We’re honored to be featured on the Hardware FYI Robotics & Autonomous Systems Market Map! 🎉 This list showcases the game-changers in robotics—companies making waves in industries like pharma (that’s us!), warehouse logistics, agriculture, and more. At Multiply Labs, we’re on a mission to reshape personalized therapy manufacturing with cutting-edge automation. Curious to see the full lineup? Check it out here: https://tally.so/r/waZo0b #Pharma #Robotics #Humanoid #Automation #Robots

At this year's GenScript Biotech Global Forum, we saw firsthand how an interconnected ecosystem of industry players can come together to shape the future of the cell and gene therapy manufacturing space. The panels, including the one Jonathan H. Esensten, M.D., Ph.D. participated in, highlighted the importance of integrated approaches in the shared progress of the industry as a whole. Collaboration is at the heart of our mission at Multiply Labs to make personalized therapy manufacturing more scalable and affordable, bringing life-saving treatments to patients who need them. Our partnership with GenScript is proof that when we work together, we can create breakthroughs in the biopharma space by leveraging the complementary strengths of industry leaders. By integrating GenScript’s CytoSinct 1000 technology into our automated robotic cluster, we are proud to show the first fully automated solution for bead-based cell isolation - a massive stride towards our goal of a fully automated, end-to-end therapy manufacturing process. 🎥 Watch the video to see our robotic system in action! #Biotech #CellTherapy #Automation #Pharma #Partnership #BGF2025

🚨 The GenScript Biotech Global Forum 2025 is this Wednesday, and we can’t wait to join the brightest minds in cell and gene therapy to explore innovations and breakthroughs shaping tomorrow’s treatments. We’re honored to be part of this transformative event and to showcase our partnership with GenScript - together we are revolutionizing cell therapy manufacturing by combining their CytoSinct 1000 technology with our advanced robotic automation. On January 15th, our Senior Advisor, Dr. Jonathan H. Esensten, M.D., Ph.D., will be taking the stage alongside Dr. Jason Bock, Rey (Reut) Mali, Dr. Matthew Pillar, Dr. Hari Pujar, Michael Vreeland, MS, and Dr. Hing Wong to discuss what’s needed to conquer cell and gene therapy’s biggest challenges in biomanufacturing and supply chain management. Will we see you there? Let us know in the comments! #BGF2025 #CellAndGeneTherapy #Biomanufacturing #Biotech #CellTherapy #Automation #JPM25

From groundbreaking partnerships in the robotics and pharma sectors to tangible advancements in automated cell therapy manufacturing, 2024 was a huge year for Multiply Labs. 🚀 Thank you, Shreeyashi Ojha, for featuring us among this year’s game-changers in BioProcess International Insider’s Wrapped for 2024! With robotics and automation shaping the future of cell and gene therapy manufacturing we’re honored to be at the forefront of this revolution. Let’s take a closer look at some of the top trends from 2024: 🤖  The rise of AI, automation, and robotics in pharma drove industry change. This year showcased a clear focus on integrating advanced technology to modernize cell and gene therapy manufacturing, making processes more efficient and reliable. 🔄The post-pandemic slowdown led to widespread operational realignments across the biopharma sector. Companies reassessed their strategies, focusing on core strengths, streamlining partnerships, and prioritizing high-impact initiatives, underscoring the importance of scalable and lean manufacturing solutions. 🏭The industry also saw significant shifts in manufacturing capacity and strategic consolidations, highlighting the need for flexible, scalable solutions to meet growing demands in a rapidly evolving market. Check out the full article for more insights into 2024’s key developments👉 https://lnkd.in/gXXrNvED #Biopharma #CellTherapy #Automation #Robotics